{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T00:32:12Z","timestamp":1790382732893,"version":"4.1.0"},"reference-count":51,"publisher":"Japan Atherosclerosis Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAT","J Atheroscler Thromb"],"published-print":{"date-parts":[[2022,1,1]]},"DOI":"10.5551\/jat.54379","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T22:08:20Z","timestamp":1610662100000},"page":"111-125","source":"Crossref","is-referenced-by-count":27,"title":["Nanoparticle-Mediated Delivery of Pitavastatin to Monocytes\/Macrophages Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in <i>Apoe<\/i><sup>\u2212\/\u2212<\/sup> Mice"],"prefix":"10.5551","volume":"29","author":[{"given":"Shunsuke","family":"Katsuki","sequence":"first","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-ichiro","family":"Koga","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Matoba","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuta","family":"Umezu","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soichi","family":"Nakashiro","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaku","family":"Nakano","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Tsutsui","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Medicine, Graduate School of Medical Sciences, Kyushu University"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kensuke","family":"Egashira","sequence":"additional","affiliation":[{"name":"The Department of Cardiovascular Research, Development, and Translational Medicine, Center for Disruptive Cardiovascular Innovation, Kyushu University"},{"name":"The Department of Translational Medicine, Kyushu University Graduate School of Pharmaceutical Sciences"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3489","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Benjamin EJ, Blaha MJ, Chiuve SE, Cushman M, Das SR, Deo R, de Ferranti SD, Floyd J, Fornage M, Gillespie C, Isasi CR, Jimenez MC, Jordan LC, Judd SE, Lackland D, Lichtman JH, Lisabeth L, Liu S, Longenecker CT, Mackey RH, Matsushita K, Mozaffarian D, Mussolino ME, Nasir K, Neumar RW, Palaniappan L, Pandey DK, Thiagarajan RR, Reeves MJ, Ritchey M, Rodriguez CJ, Roth GA, Rosamond WD, Sasson C, Towfighi A, Tsao CW, Turner MB, Virani SS, Voeks JH, Willey JZ, Wilkins JT, Wu JH, Alger HM, Wong SS, Muntner P, American Heart Association Statistics C and Stroke Statistics S. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation, 2017; 135: e146-e603","DOI":"10.1161\/CIR.0000000000000485"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Powell JT, Brady AR, Brown LC, Forbes JF, Fowkes FGR, Greenhalgh RM, Ruckley CV, Thompson SG and Participants USAT. Mortality results for randomised controlled trial of early elective surgery or ultrasonographic surveillance for small abdominal aortic aneurysms. Lancet, 1998; 352: 1649-1655","DOI":"10.1016\/S0140-6736(98)10137-X"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) De Bruin JL, Baas AF, Buth J, Prinssen M, Verhoeven ELG, Cuypers PWM, van Sambeek MRHM, Balm R, Grobbee DE, Blankensteijn JD and Grp DS. Long-Term Outcome of Open or Endovascular Repair of Abdominal Aortic Aneurysm. New Engl J Med, 2010; 362: 1881-1889","DOI":"10.1056\/NEJMoa0909499"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Greenhalgh RM, Brown LC, Powell JT, Thompson SG and Epstein D. Endovascular repair of aortic aneurysm in patients physically ineligible for open repair. N Engl J Med, 2010; 362: 1872-1880","DOI":"10.1056\/NEJMoa0911056"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Lederle FA, Freischlag JA, Kyriakides TC, Matsumura JS, Padberg FT, Kohler TR, Kougias P, Jean-Claude JM, Cikrit DF, Swanson KM and Study OVAC. Long-Term Comparison of Endovascular and Open Repair of Abdominal Aortic Aneurysm. New Engl J Med, 2012; 367: 1988-1997","DOI":"10.1056\/NEJMoa1207481"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Kent KC. Clinical practice. Abdominal aortic aneurysms. N Engl J Med, 2014; 371: 2101-2108","DOI":"10.1056\/NEJMcp1401430"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Lu H and Daugherty A. Aortic Aneurysms. Arterioscl Throm Vas, 2017; 37: E59-E65","DOI":"10.1161\/ATVBAHA.117.309578"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) McCormick ML, Gavrila D and Weintraub NL. Role of oxidative stress in the pathogenesis of abdominal aortic aneurysms. Arterioscl Throm Vas, 2007; 27: 461-469","DOI":"10.1161\/01.ATV.0000257552.94483.14"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Weintraub NL. Understanding Abdominal Aortic Aneurysm. New Engl J Med, 2009; 361: 1114-1116","DOI":"10.1056\/NEJMcibr0905244"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Shimizu K, Mitchell RN and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscl Throm Vas, 2006; 26: 987-994","DOI":"10.1161\/01.ATV.0000214999.12921.4f"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Manning MW, Cassis LA and Daugherty A. Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms. Arterioscl Throm Vas, 2003; 23: 483-488","DOI":"10.1161\/01.ATV.0000058404.92759.32"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Raffort J, Lareyre F, Clement M, Hassen-Khodja R, Chinetti G and Mallat Z. Monocytes and macrophages in abdominal aortic aneurysm. Nat Rev Cardiol, 2017; 14: 457-471","DOI":"10.1038\/nrcardio.2017.52"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) de Waard V, Bot I, de Jager SC, Talib S, Egashira K, de Vries MR, Quax PH, Biessen EA and van Berkel TJ. Systemic MCP1\/CCR2 blockade and leukocyte specific MCP1\/CCR2 inhibition affect aortic aneurysm formation differently. Atherosclerosis, 2010; 211: 84-89","DOI":"10.1016\/j.atherosclerosis.2010.01.042"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Pope NH, Salmon M, Davis JP, Chatterjee A, Su G, Conte MS, Ailawadi G and Upchurch GR. D-series resolvins inhibit murine abdominal aortic aneurysm formation and increase M2 macrophage polarization. Faseb J, 2016; 30: 4192-4201","DOI":"10.1096\/fj.201600144RR"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Takemoto M and Liao JK. Pleiotropic effects of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors. Arterioscler Thromb Vasc Bio, 2001; 21: 1712-1719","DOI":"10.1161\/hq1101.098486"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Zhang YL, Naggar JC, Welzig CM, Beasley D, Moulton KS, Park HJ and Galper JB. Simvastatin Inhibits Angiotensin II-Induced Abdominal Aortic Aneurysm Formation in Apolipoprotein E-Knockout Mice Possible Role of ERK. Arterioscl Throm Vas, 2009; 29: 1764-U110","DOI":"10.1161\/ATVBAHA.109.192609"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Li YY, Lu GS, Sun DT, Zuo HJ, Wang DW and Yan JT. Inhibition of endoplasmic reticulum stress signaling pathway: A new mechanism of statins to suppress the development of abdominal aortic aneurysm. Plos One, 2017; 12","DOI":"10.1371\/journal.pone.0174821"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Golledge J, Cullen B, Moran C and Rush C. Efficacy of Simvastatin in Reducing Aortic Dilatation in Mouse Models of Abdominal Aortic Aneurysm. Cardiovasc Drug Ther, 2010; 24: 373-378","DOI":"10.1007\/s10557-010-6262-8"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang JA, Chen WA, Wang Y, Zhang S, Bi H, Hong B, Luo Y, Daugherty A and Xie X. Statins exert differential effects on angiotensin II-induced atherosclerosis, but no benefit for abdominal aortic aneurysms. Atherosclerosis, 2011; 217: 90-96","DOI":"10.1016\/j.atherosclerosis.2011.03.005"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Sukhija R, Aronow WS, Sandhu R, Kakar P and Babu S. Mortality and size of abdominal aortic aneurysm at long-term follow-up of patients not treated surgically and treated with and without statins. Am J Cardiol, 2006; 97: 279-280","DOI":"10.1016\/j.amjcard.2005.08.033"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21) Schouten O, van Laanen JH, Boersma E, Vidakovic R, Feringa HH, Dunkelgrun M, Bax JJ, Koning J, van Urk H and Poldermans D. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur J Vasc Endovasc Surg, 2006; 32: 21-26","DOI":"10.1016\/j.ejvs.2005.12.024"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22) Takagi H, Matsui M and Umemoto T. A meta-analysis of clinical studies of statins for prevention of abdominal aortic aneurysm expansion. J Vasc Surg, 2010; 52: 1675-1681","DOI":"10.1016\/j.jvs.2010.04.082"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23) Katsuki S, Matoba T, Koga JI, Nakano K and Egashira K. Anti-inflammatory Nanomedicine for Cardiovascular Disease. Front Cardiovasc Med, 2017; 4: 87","DOI":"10.3389\/fcvm.2017.00087"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24) Koga J, Matoba T and Egashira K. Anti-inflammatory Nanoparticle for Prevention of Atherosclerotic Vascular Diseases. J Atheroscler Thromb, 2016; 23: 757-765","DOI":"10.5551\/jat.35113"},{"key":"25","doi-asserted-by":"crossref","unstructured":"25) Nakashiro S, Matoba T, Umezu R, Koga J, Tokutome M, Katsuki S, Nakano K, Sunagawa K and Egashira K. Pioglitazone-Incorporated Nanoparticles Prevent Plaque Destabilization and Rupture by Regulating Monocyte\/Macrophage Differentiation in ApoE(-\/-) Mice. Arterioscl Throm Vas, 2016; 36: 491-500","DOI":"10.1161\/ATVBAHA.115.307057"},{"key":"26","doi-asserted-by":"crossref","unstructured":"26) Kubo M, Egashira K, Inoue T, Koga J, Oda S, Chen L, Nakano K, Matoba T, Kawashima Y, Hara K, Tsujimoto H, Sueishi K, Tominaga R and Sunagawa K. Therapeutic Neovascularization by Nanotechnology-Mediated Cell-Selective Delivery of Pitavastatin Into the Vascular Endothelium. Arterioscl Throm Vas, 2009; 29: 796-U47","DOI":"10.1161\/ATVBAHA.108.182584"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27) Chen L, Nakano K, Kimura S, Matoba T, Iwata E, Miyagawa M, Tsujimoto H, Nagaoka K, Kishimoto J, Sunagawa K and Egashira K. Nanoparticle-mediated delivery of pitavastatin into lungs ameliorates the development and induces regression of monocrotaline-induced pulmonary artery hypertension. Hypertension, 2011; 57: 343-350","DOI":"10.1161\/HYPERTENSIONAHA.110.157032"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28) Katsuki S, Matoba T, Nakashiro S, Sato K, Koga J, Nakano K, Nakano Y, Egusa S, Sunagawa K and Egashira K. Nanoparticle-Mediated Delivery of Pitavastatin Inhibits Atherosclerotic Plaque Destabilization\/Rupture in Mice by Regulating the Recruitment of Inflammatory Monocytes. Circulation, 2014; 129: 896-906","DOI":"10.1161\/CIRCULATIONAHA.113.002870"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29) Nagaoka K, Matoba T, Mao YJ, Nakano Y, Ikeda G, Egusa S, Tokutome M, Nagahama R, Nakano K, Sunagawa K and Egashira K. A New Therapeutic Modality for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin Induces Cardioprotection from Ischemia-Reperfusion Injury via Activation of PI3K\/Akt Pathway and Anti-Inflammation in a Rat Model. Plos One, 2015; 10","DOI":"10.1371\/journal.pone.0132451"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30) Ichimura K, Matoba T, Nakano K, Tokutome M, Honda K, Koga J and Egashira K. A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model. Plos One, 2016; 11","DOI":"10.1371\/journal.pone.0162425"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31) Daugherty A, Manning MW and Cassis LA. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest, 2000; 105: 1605-1612","DOI":"10.1172\/JCI7818"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32) Murakami H, Kobayashi M, Takeuchi H and Kawashima Y. Preparation of poly(DL-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method. Int J Pharm, 1999; 187: 143-152","DOI":"10.1016\/S0378-5173(99)00187-8"},{"key":"33","doi-asserted-by":"crossref","unstructured":"33) Kawashima Y, Yamamoto H, Takeuchi H, Hino T and Niwa T. Properties of a peptide containing DL-lactide\/glycolide copolymer nanospheres prepared by novel emulsion solvent diffusion methods. Eur J Pharm Biopharm, 1998; 45: 41-48","DOI":"10.1016\/S0939-6411(97)00121-5"},{"key":"34","doi-asserted-by":"crossref","unstructured":"34) Ishibashi M, Egashira K, Zhao Q, Hiasa K, Ohtani K, Ihara Y, Charo IF, Kura S, Tsuzuki T, Takeshita A and Sunagawa K. Bone marrow-derived monocyte chemoattractant protein-1 receptor CCR2 is critical in angiotensin II-induced acceleration of atherosclerosis and aneurysm formation in hypercholesterolemic mice. Arterioscler Thromb Vasc Biol, 2004; 24: e174-178","DOI":"10.1161\/01.ATV.0000143384.69170.2d"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35) Daugherty A, Manning MW and Cassis LA. Antagonism of AT2 receptors augments Angiotensin II-induced abdominal aortic aneurysms and atherosclerosis. Brit J Pharmacol, 2001; 134: 865-870","DOI":"10.1038\/sj.bjp.0704331"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36) Satoh K, Nigro P, Matoba T, O\u2019Dell MR, Cui Z, Shi X, Mohan A, Yan C, Abe J, Illig KA and Berk BC. Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med, 2009; 15: 649-656","DOI":"10.1038\/nm.1958"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37) Koga J, Nakano T, Dahlman JE, Figueiredo JL, Zhang HM, Decano J, Khan OF, Niida T, Iwata H, Aster JC, Yagita H, Anderson DG, Ozaki CK and Aikawa M. Macrophage Notch Ligand Delta-Like 4 Promotes Vein Graft Lesion Development Implications for the Treatment of Vein Graft Failure. Arterioscl Throm Vas, 2015; 35: 2343-2353","DOI":"10.1161\/ATVBAHA.115.305516"},{"key":"38","doi-asserted-by":"crossref","unstructured":"38) Gitlin JM, Trivedi DB, Langenbach R and Loftin CD. Genetic deficiency of cyclooxygenase-2 attenuates abdominal aortic aneurysm formation in mice. Cardiovasc Res, 2007; 73: 227-236","DOI":"10.1016\/j.cardiores.2006.10.015"},{"key":"39","doi-asserted-by":"crossref","unstructured":"39) Sun Y, Chen L, Zhao S, Shi L, Li H, Tian W and Qi G. Effects of nanoparticle-mediated delivery of pitavastatin on atherosclerotic plaques in ApoE-knockout mice and THP-1-derived macrophages. Exp Ther Med, 2020; 19: 3787-3797","DOI":"10.3892\/etm.2020.8632"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40) Sun JS, Sukhova GK, Zhang J, Chen H, Sjoberg S, Libby P, Xia MC, Xiong N, Gelb BD and Shi GP. Cathepsin K Deficiency Reduces Elastase Perfusion-Induced Abdominal Aortic Aneurysms in Mice. Arterioscl Throm Vas, 2012; 32: 15-U68","DOI":"10.1161\/ATVBAHA.111.235002"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41) Nosoudi N, Nahar-Gohad P, Sinha A, Chowdhury A, Gerard P, Carsten CG, Gray BH and Vyavahare NR. Prevention of Abdominal Aortic Aneurysm Progression by Targeted Inhibition of Matrix Metalloproteinase Activity With Batimastat-Loaded Nanoparticles. Circ Res, 2015; 117: E80-E89","DOI":"10.1161\/CIRCRESAHA.115.307207"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42) Busuttil RW, Rinderbriecht H, Flesher A and Carmack C. Elastase Activity - the Role of Elastase in Aortic-Aneurysm Formation. J Surg Res, 1982; 32: 214-217","DOI":"10.1016\/0022-4804(82)90093-2"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43) Hellenthal FA, Buurman WA, Wodzig WK and Schurink GW. Biomarkers of AAA progression. Part 1: extracellular matrix degeneration. Nat Rev Cardiol, 2009; 6: 464-474","DOI":"10.1038\/nrcardio.2009.80"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44) Pyo R, Lee JK, Shipley JM, Curci JA, Mao D, Ziporin SJ, Ennis TL, Shapiro SD, Senior RM and Thompson RW. Targeted gene disruption of matrix metalloproteinase-9 (gelatinase B) suppresses development of experimental abdominal aortic aneurysms. J Clin Invest, 2000; 105: 1641-1649","DOI":"10.1172\/JCI8931"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45) Senior RM, Griffin GL, Fliszar CJ, Shapiro SD, Goldberg GI and Welgus HG. Human 92- and 72-kilodalton type IV collagenases are elastases. J Biol Chem, 1991; 266: 7870-7875","DOI":"10.1016\/S0021-9258(20)89530-1"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46) Baxter BT, Terrin MC and Dalman RL. Medical management of small abdominal aortic aneurysms. Circulation, 2008; 117: 1883-1889","DOI":"10.1161\/CIRCULATIONAHA.107.735274"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47) Lederle FA, Noorbaloochi S, Nugent S, Taylor BC, Grill JP, Kohler TR and Cole L. Multicentre study of abdominal aortic aneurysm measurement and enlargement. Br J Surg, 2015; 102: 1480-1487","DOI":"10.1002\/bjs.9895"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48) Miyake T and Morishita R. Pharmacological treatment of abdominal aortic aneurysm. Cardiovasc Res, 2009; 83: 436-443","DOI":"10.1093\/cvr\/cvp155"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49) Yoshimura K, Aoki H, Ikeda Y, Fujii K, Akiyama N, Furutani A, Hoshii Y, Tanaka N, Ricci R, Ishihara T, Esato K, Hamano K and Matsuzaki M. Regression of abdominal aortic aneurysm by inhibition of c-Jun N-terminal kinase. Nat Med, 2005; 11: 1330-1338","DOI":"10.1038\/nm1335"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50) Nagashima H, Aoka Y, Sakomura Y, Sakuta A, Aomi S, Ishizuka N, Hagiwara N, Kawana M and Kasanuki H. A 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, cerivastatin, suppresses production of matrix metalloproteinase-9 in human abdominal aortic aneurysm wall. J Vasc Surg, 2002; 36: 158-163","DOI":"10.1067\/mva.2002.123680"},{"key":"51","unstructured":"51) Aoki T, Nishimura H, Nakagawa S, Kojima J, Suzuki H, Tamaki T, Wada Y, Yokoo N, Sato F, Kimata H, Kitahara M, Toyoda K, Sakashita M and Saito Y. Pharmacological profile of a novel synthetic inhibitor of 3-hydroxy-3-methylglutaryl-coenzyme A reductase. Arzneimittelforschung, 1997; 47: 904-909"}],"container-title":["Journal of Atherosclerosis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_54379\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T04:37:01Z","timestamp":1715143021000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jat\/29\/1\/29_54379\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,1]]},"references-count":51,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.5551\/jat.54379","relation":{},"ISSN":["1340-3478","1880-3873"],"issn-type":[{"value":"1340-3478","type":"print"},{"value":"1880-3873","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,1]]},"article-number":"54379"}}